Quick Dispatch:
Your tirzepatide pediatric Why the FDA Approved Mounjaro for Children Age 10+ with Type 2 Diabetes orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide pediatric Why the FDA Approved Mounjaro for Children Age 10+ with Type 2 Diabetes ships.
Need Help?
Questions about tirzepatide pediatric Why the FDA Approved Mounjaro for Children Age 10+ with Type 2 Diabetes, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide pediatric Why the FDA Approved Mounjaro for Children Age 10+ with Type 2 Diabetes in your area.
Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️
27.57
01774-X/asset/3608bfb3-6329-4132-95b7-cc3434437493/main.assets/gr2_lrg.jpg)
Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial
21.02
Mounjaro approved for use in children in UK in 'significant advance in paediatric care'
28.10
🚨 Diabetes News Update for Families 🚨 Big update in pediatric diabetes care 👇 Mounjaro (tirzepatide) is now approved for children and adolescents ages 10 and older with type 2 diabetes. This
25.93
01774-X/asset/29980040-bf4f-4117-ad08-f431cfca3ffc/main.assets/gr3_lrg.jpg)
Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial
20.72
OTP Exclusive: FDA Expands Mounjaro Label to Include Pediatric Patients Aged 10 and Older
29.91
Aristopharma
21.22
